Published Technical Disclosure Archive

Advanced Robotic Clot Manipulation and Removal Systems

Publication ID: 24-11857277_0005_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Advanced Robotic Clot Manipulation and Removal Systems,” Published Technical Disclosure No. 24-11857277_0005_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857277_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,277.

Summary of the Inventive Concept

This inventive concept envisions a next-generation robotic system for clot manipulation and removal, leveraging AI-assisted navigation, real-time imaging feedback, and advanced haptic feedback to optimize treatment outcomes and revolutionize the field of vascular medicine.

Background and Problem Solved

The original patent disclosed a robotically controlled system for clot removal, but it had limitations in terms of navigation, precision, and adaptability. The new inventive concept addresses these limitations by incorporating cutting-edge technologies to provide more effective and efficient clot removal procedures.

Detailed Description of the Inventive Concept

The advanced robotic system features AI-assisted navigation, which enables real-time tracking of the clot and optimal instrument positioning. The system also incorporates real-time imaging feedback, allowing for precise monitoring of the procedure and instant adjustments. Additionally, the system includes advanced haptic feedback, enabling the physician to remotely manipulate the instrument with enhanced precision and tactile sensitivity. The system can be configured to accommodate varying clot sizes and shapes through a dynamically adjustable working channel.

Novelty and Inventive Step

The new inventive concept introduces a paradigm shift in clot removal technology by integrating AI-assisted navigation, real-time imaging feedback, and advanced haptic feedback. These features, combined with the dynamically adjustable working channel, provide a significant improvement over the original patent and make the new system more effective, efficient, and adaptable.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of swarm robotics, where multiple micro-robots are deployed to disintegrate and evacuate the clot. Another variation could involve the development of a cloud-based platform for remote clot removal procedures, enabling real-time collaboration and consultation between medical professionals.

Potential Commercial Applications and Market

The advanced robotic clot manipulation and removal system has significant commercial potential in the vascular medicine market, particularly in the areas of stroke treatment, peripheral artery disease, and pulmonary embolism. The system's ability to optimize treatment outcomes and reduce procedure times could lead to increased adoption and market share.

CPC Classifications

SectionClassGroup
A A61 A61B34/30
A A61 A61B17/12136
A A61 A61B17/3207
A A61 A61B2017/22038
A A61 A61B2034/301
A A61 A61B2034/303
A A61 A61B2090/08021

Field of Art

Medical device robotics, specifically interventional vascular clot removal systems, requiring advanced mechanical engineering, robotics, medical instrumentation, and minimally invasive surgical technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in robotic surgical systems, interventional radiology, and advanced catheter-based medical technologies, holding advanced degrees and 5-10 years of specialized experience

Obviousness Rationale

A PHOSITA would recognize that the PTD's AI-assisted navigation, real-time imaging feedback, and advanced haptic control represent predictable technological improvements to the existing robotic clot removal system. These variations leverage known techniques in medical robotics and represent incremental advancements that would be obvious to implement given the foundational teachings of the source patent. The integration of AI, imaging, and haptic feedback are logical extensions of the existing robotic manipulation technology.

Obvious Combinations & Variations

Source Patent Element
Robotically controlled instrument system with multiple elongate members for clot manipulation
PTD Variation
AI-assisted navigation for precise instrument positioning and clot tracking
Obviousness Reasoning
Adding AI guidance to robotic medical instruments is a known technique for improving procedural accuracy, representing a predictable application of machine learning to existing robotic systems
Source Patent Element
Instrument system capable of physically modifying clots
PTD Variation
Swarm robotics approach using multiple micro-robots to disintegrate clots
Obviousness Reasoning
Deploying multiple small robotic elements to accomplish a complex medical task is an obvious variation that extends the source patent's core concept of mechanical clot manipulation
Source Patent Element
Coaxial elongate members with articulation capabilities
PTD Variation
Dynamically adjustable working channel that can reconfigure in real-time
Obviousness Reasoning
Adaptive instrument geometries are a predictable design evolution in medical robotics, representing a finite set of obvious modifications to improve procedural flexibility
Source Patent Element
Robotic clot removal instrument system
PTD Variation
Advanced haptic feedback enabling remote precision manipulation
Obviousness Reasoning
Enhancing physician control through improved tactile feedback is a known technique in robotic surgical systems, representing an obvious improvement to existing technologies
Source Patent Element
Instrument system for vascular intervention
PTD Variation
Cloud-based platform enabling remote collaboration and data-driven insights
Obviousness Reasoning
Integrating telemedicine and data sharing capabilities is an obvious technological progression for medical robotic systems, leveraging established cloud computing techniques
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this publication would be obvious to a Person Having Ordinary Skill In The Art in medical robotics, when viewed in light of US Patent 11857277. The incremental technological improvements represent predictable extensions of the source patent's core teachings, utilizing known techniques in AI navigation, haptic feedback, and robotic medical instrumentation to enhance clot removal methodologies.

Original Patent Information

Patent NumberUS 11,857,277
TitleRobotically controlled clot manipulation and removal
Assignee(s)Auris Health, Inc.